Roots Analysis

MAY 21, 2024

Proteins are the chains of amino acids linked together in different combinations and perform a wide variety of functions. However, continuous regulation of the cellular proteome is essential for maintaining the right balance of different proteins necessary for normal cellular function, survival, and proliferation.

Protein 40

Protein Marketing Development Antibody 40

pharmaphorum

AUGUST 18, 2020

This is a question that a consortium of European pharma companies hopes to answer as it aims to rapidly develop new therapies to combat the pandemic. The trick is to look for proteins that are used across all coronavirus types and tend not to vary much from one virus species to another. But also included in the 77.7

Protein 121

Protein Pharma Companies RNA Drugs 121

BioPharma Reporter

JUNE 27, 2024

The new generative AI model released by EvolutionaryScale will be used by researchers and pharma companies to empower drug discovery.

Protein 52

Protein Pharma Companies Drugs Research 52

The Pharma Data

DECEMBER 20, 2020

SN14 works by targeting the coronavirus’ nucleocapsid and spike proteins to prevent viral replication using the company’s ImmunoBody DNA vaccine technology. UK drug developer Scancell said it has chosen a COVID-19 vaccine candidate, SN14, from more than a dozen potential products to advance to a clinical trial. .

Clinical Trials 52

Clinical Trials Clinical Trials Pharma Companies Vaccine 52

pharmaphorum

AUGUST 7, 2020

It is part of a five-point plan by Pfizer launched in March that urged all pharma companies and biotechs to work together with government agencies and academic institutions to tackle the COVID-19 pandemic. Pfizer will provide contract manufacturing services at its facility in McPherson, Kansas, to supply the drug to Gilead.

Manufacturing 119

Manufacturing Contract Manufacturing Protein Allergies 119

BioPharma Reporter

NOVEMBER 6, 2023

The big pharma company Bristol Myers Squibb (BMS) committed up to $180 million for a phase 1-ready antibody-drug conjugate (ADC) for the treatment of blood cancer from the U.S.-South South Korean biotech company Orum Therapeutics.

Protein 52

Protein Pharma Companies Antibody Drugs 52

pharmaphorum

FEBRUARY 16, 2021

Inflammasomes are a group of intracellular proteins associated with the inflammatory response, and prior research has linked the NLRP3 inflammasome to the aggregation of amyloid beta and tau protein – which together form the characteristic plaques and tangles in the brains of AD patients.

Research 119

Research Drugs Protein Development 119

Delveinsight

SEPTEMBER 3, 2021

The post Charcot-Marie-Tooth Disease Market Size Expects Growth Owing to Increasing Prevalence, Influx of Pharma Companies and Novel Therapies appeared first on DelveInsight Business Research.

Pharma Companies 52

Pharma Companies Marketing Clinical Trials Clinical Trials 52

pharmaphorum

APRIL 21, 2022

One of the leading companies in the bid to bring a new class of alpha-synuclein targeting drugs to market for Parkinson’s disease – AbbVie – is ducking out of the challenge. ” She added that BioArctic will now “investigate options to continue the development of this asset.”

Antibody 97

Antibody Protein Gene Therapy Pharma Companies 97

BioPharma Reporter

JULY 31, 2023

Boston-based pharma company Ratio Therapeutics has initiated dosing in a phase 1 study evaluating the pharmacokinetics, biodistribution and radiation dosimetry of a novel fibroblast activation protein-alpha (FAP)-targeted radiopharmaceutical, RTX-1363S, for PET imaging in adult healthy volunteers.

Pharma Companies 52

Pharma Companies Protein Development 52

pharmaphorum

DECEMBER 8, 2020

Its approach involves licensing rights to the antibodies to other pharma companies, rather than bringing its own candidates through development. Bamlanivimab is directed against the spike protein of SARS-CoV-2, designed to block the virus’ attachment and entry into human cells.

Drugs 111

Drugs Antibody FDA Approval Pharma Companies 111

pharmaphorum

AUGUST 23, 2021

DNA vaccines work by delivering a genetically-engineered plasmid containing the DNA sequence encoding the desired antigen – in this case the SARS-CoV-2 spike protein – which is then taken up by cells. The company also says that it can update the vaccine very easily to deal with mutations in the virus.

DNA 98

DNA Vaccine Vaccination Genetic Engineering 98

pharmaphorum

JANUARY 18, 2022

Two Spanish pharma companies are joining forces to identify new oral treatments for immune-inflammatory skin diseases with high unmet medical needs. Researchers at Almirall have identified several proteins whose abnormal function is associated with inflammatory immune skin diseases.

Dermatology 52

Dermatology Protein Pharma Companies Research 52

pharmaphorum

DECEMBER 24, 2020

Google’s AI company DeepMind grabbed many headlines in November when it solved the 50-year-‘ protein folding problem ’, but there was less theoretical progress made too with the announcement in Nature Medicine of new standards for clinical trials that involve AI. The FDA took a strategic approach to digital health. About the author.

Pharma Companies 126

Pharma Companies Clinical Trials Clinical Trials Doctors 126

pharmaphorum

FEBRUARY 9, 2022

While therapeutic cancer vaccines are able to help the body identify particular proteins expressed by cancer cells and then to instigate an immune response. The promise of this approach means that there is now a growing pipeline of potential cancer vaccines emerging from within the portfolios of larger pharma companies and biotechs.

Vaccine 134

Vaccine Vaccination Clinical Trials Clinical Trials 134

pharmaphorum

OCTOBER 11, 2022

Asked how he made the shift from working out the structure of proteins and how molecules bind to those proteins, to the founding of pharmaphorum and focusing on the digital space, his answer was clear: communication. One of the things I learned through my early academic years is that I was surrounded by brilliant people.

Medicine 98

Medicine Pharma Companies Doctors Doctor 98

pharmaphorum

NOVEMBER 6, 2022

Here are a few examples on how companies are using AI in diverse ways to accelerate antibody discovery: 1) Generate Biomedicine : Founded in 2018, it is a flagship pioneering company based in Boston and has raised $420M so far. Data generated in each test cycle is used to update AI/ML models for the next cycle of iteration.

Antibody 123

Antibody Drugs Protein Life Science 123

XTalks

JANUARY 3, 2025

Tryngolza works by targeting a protein in the liver, apoC-III, which regulates triglyceride metabolism. People with FCS often have triglyceride levels higher than 880 mg/dL, compared to a healthy target level of below 150 mg/dL. FCS also severely impacts quality of life, causing chronic fatigue and recurrent stomach pain.

FDA Approval 59

FDA Approval Drugs Clinical Trials Clinical Trials 59

The Pharma Data

SEPTEMBER 29, 2020

The collaboration has leveraged Sosei’s StaR technology and Structure-based Drug Design (SBDD) capabilities to design oral small molecules that modulate different G protein-coupled receptor (GPCR) targets across multiple disease areas.

Clinical Trials 52

Clinical Trials Clinical Trials Pharma Companies Trials 52

pharmaphorum

OCTOBER 12, 2022

Overall, the aim is to improve the efficiency of drug discovery by identifying genetic variants that contribute to human disease in omics data – a broad category that includes DNA profiles, gene transcripts, and protein expression.

Genome 64

Genome Genomics DNA Drugs 64

pharmaphorum

JANUARY 12, 2021

With the backing the company already has, Secor said the plan is to focus on preclinical development without needing to worry about funding for the time being. Quizzed about the possibility of an IPO or buyout from a big pharma company, Secor said the focus is very much on developing the technology.

RNA 95

RNA Production Development Pharma Companies 95

pharmaphorum

OCTOBER 20, 2021

The trial – which will be supported by pharma company Eisai and Ionian University in the US – will see if the test can identify people who have mild cognitive impairment (MCI) due to Alzheimer’s disease.

Trials 78

Trials Genome Genomics Bioinformatics 78

The Pharma Data

JANUARY 24, 2021

.–( BUSINESS WIRE )– Faze Medicines , a biotechnology company pioneering therapeutics based on the groundbreaking new science of biomolecular condensates, today announced that it has appointed Philip Vickers, Ph.D., Preclinical and clinical programs at Northern Biologics were acquired by big pharma companies in 2020.

Medicine 52

Medicine Pharma Companies Gene Therapy Development 52

pharmaphorum

FEBRUARY 24, 2021

Changes in the “Spike” protein targeted by nearly all the vaccines approved or in development could also lead to more infectious variants, such as the strain that emerged in Kent and is now prevalent across most of the UK. Manufacturers are also encouraged to study the response in previously vaccinated and unvaccinated people.

Vaccine 59

Vaccine Vaccination Immune Response Regulation 59

pharmaphorum

JANUARY 18, 2022

Biotech / Pharma Companies – Team Leader, Junior Principle investigator, Cell and Molecular Scientist, Chief Scientific Officer, Deputy Director, Manager, Founder, CEO, Head, Director, Programme Manager, Lab Head, Toxicologist. Who Should Attend?

In-Vitro 52

In-Vitro Engineer Drugs Pharma Companies 52

pharmaphorum

MAY 13, 2022

According to BridgeBio and other SHP2 developers like Revolution Medicines, Jacobio, Erasca, Redx Pharma and Relay Therapeutics, the phosphatase enzyme – once considered “undruggable” – is over-expressed in a number of different solid tumour types. The post BMS doubles down on BridgeBio alliance on SHP2 drugs appeared first on.

Drugs 59

Drugs Pharma Companies Medicine Licensing 59

pharmaphorum

DECEMBER 7, 2021

The deal – which is weighted heavily towards neuroscience with just one cancer programme covered – is the second between Recursion and a big pharma company in the space of two days, coming on the heels of a smaller alliance with Bayer that will look for new fibrosis drugs.

Drugs 59

Drugs RNA Pharma Companies Protein 59

pharmaphorum

FEBRUARY 28, 2022

Studies have suggested that some patients with COVID-19 exhibit marked increases in autoantibody reactivities as compared to uninfected individuals, including some that seem to target immune components like cytokines, chemokines and complement proteins. The deal was announced as Oncimmune reported half-year revenues of £1.4 million ($1.9

Life Science 52

Life Science Pharma Companies Development Protein 52

pharmaphorum

DECEMBER 1, 2022

Biotech / Pharma Companies – Investigative toxicologist, Research Scientist, Clinical Pharmacologist, Cell Technologists, Cell and Molecular Scientist, Head of Translational Research, In-Vitro Toxicologists, Director of Drug Discovery, Head of DMPK, Chief Scientific Officer, R&D Scientist, Head of R&D. Who Should Attend?

In-Vitro 52

In-Vitro Scientist Engineer Gene Therapy 52

pharmaphorum

NOVEMBER 12, 2020

The mid-sized pharma group has also signed a collaboration with Florida, US-based Lacerta Therapeutics , adding more AAV capsids – well established as a staple for delivering gene therapy sequences – as well as another gene therapy candidate.

Gene Therapy 52

Gene Therapy Gene Manufacturing Contract Manufacturing 52

Delveinsight

FEBRUARY 9, 2021

The move came not long after healthcare investor giant Deerfield Management has forged a partnership to create the Center for Protein Degradation, investing worth USD 80 million. As per the company, their one-time CAR-T cell therapy will be crucial in clinical practice in relapsed or refractory large B-cell lymphoma cases.

FDA Approval 52

FDA Approval Marketing Research Protein 52

pharmaphorum

APRIL 1, 2021

For example, you can simulate what would happen if you inhibited thousands of different proteins in thousands of different cell models.”. “Once you have the simulated cell, you can use it just as you would in any other biological model,” says Nagy. So what do they do? “You

Bioinformatics 123

Bioinformatics Drugs Development Scientist 123

pharmaphorum

NOVEMBER 23, 2021

Preliminary data has shown that the drug can reduce levels of HSD17B13 protein as well as other liver enzymes that are biomarkers for NASH. ARO-HSD is in an early-stage study involving health volunteers, and the upfront cash has already been earmarked for a phase 1/2 trial that will involve patients with NASH or suspected NASH.

Sales 52

Sales Drugs Trials RNA 52

XTalks

DECEMBER 27, 2022

The pharma company will expand its manufacturing capacity for commercial scale vector production for oncology treatment. Then, the cells translate the DNA sequence of the gene and secrete high amounts of the protein interferon alfa-2b. This protein is naturally occurring in the human body and the body uses it to fight cancer.

Gene Therapy 52

Gene Therapy FDA Approval Gene Clinical Trials 52

Delveinsight

FEBRUARY 18, 2021

During the whole process, Fibrinogen, the most abundant protein of the blood plasma after albumin and immunoglobulins, gets converted into insoluble protein fibrin. There is only a limited number of pharma companies that are working to develop therapies in the Hypofibrinogenemia market.

Marketing 52

Marketing Protein Bacteria Pharma Companies 52

Delveinsight

AUGUST 10, 2020

The cannabinoid d-9-TH binds to two types of G-protein-coupled cannabinoid receptors, CB1 and CB2 predominantly expressed in the brain (Pertwee 1997). Since cannabis is illicit in several countries and is consumed widely recreationally, pharma companies have also started to file for the patents. Medical Marijuana Market.

Marketing 96

Marketing Clinical Trials Clinical Trials Pharma Companies 96

pharmaphorum

MARCH 11, 2022

However, the financial success that has been delivered to certain companies working on vaccine development has emerged after a long period where investing in the space had become increasingly unpopular among the larger pharma companies.

Vaccine 81

Vaccine Vaccination Development Manufacturing 81